DENTSPLY SIRONA (NASDAQ:XRAY) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) released its quarterly earnings data on Tuesday. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01), FiscalAI reports. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.02%. The business had revenue of $880.00 million for the quarter, compared to analysts’ expectations of $841.80 million. During the same period last year, the business earned $0.43 earnings per share. The company’s quarterly revenue was up .1% on a year-over-year basis. DENTSPLY SIRONA updated its FY 2026 guidance to 1.400-1.500 EPS.

Here are the key takeaways from DENTSPLY SIRONA’s conference call:

• Management says the company has begun executing its Return-to-Growth action plan and is maintaining full-year 2026 guidance of $3.5B–$3.6B in sales and $1.40–$1.50 adjusted EPS, expecting clearer benefits in the back half of the year and into 2027–28.
• Q1 revenue was $880M (+0.1% reported) but declined 6.7% on a constant-currency basis; adjusted EBITDA margin contracted ~430 bps and gross profit fell ~560 bps due to lower volumes, mix and tariff headwinds, with OIS down 13.5% (7.6% ex-Byte) and implant volumes weaker across regions; adjusted EPS was $0.27.
• Early cost and balance-sheet actions showed progress—OpEx down ≈$20M (constant currency), a restructuring targeting ~$120M in annual savings, ~$80M of debt retired in the quarter, $190M cash on hand and a continued focus on deleveraging before potential share repurchases.
• Commercial and innovation momentum highlighted by new product approvals and launches (FDA/CE-cleared AI diagnostic SmartView Detect, dental MRI clearance, new endo tools, Wellspect lineup expansion) plus expanded U.S. distributor agreements (e.g., Atlanta Dental Supply, early Benco CEREC install) that management says will support longer-term growth.

DENTSPLY SIRONA Trading Down 2.0%

Shares of NASDAQ:XRAY opened at $11.14 on Thursday. The stock has a market capitalization of $2.23 billion, a price-to-earnings ratio of -3.54, a PEG ratio of 1.34 and a beta of 0.93. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.03 and a current ratio of 1.51. The stock’s 50-day simple moving average is $12.11 and its two-hundred day simple moving average is $12.01. DENTSPLY SIRONA has a 52-week low of $9.85 and a 52-week high of $17.18.

Wall Street Analyst Weigh In

XRAY has been the topic of several recent analyst reports. Zacks Research raised DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Citigroup started coverage on DENTSPLY SIRONA in a research report on Wednesday, April 15th. They issued a “sell” rating and a $10.00 target price on the stock. Wells Fargo & Company raised their target price on DENTSPLY SIRONA from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Mizuho dropped their target price on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday. Finally, Robert W. Baird raised their target price on DENTSPLY SIRONA from $12.00 to $14.00 and gave the stock a “neutral” rating in a research report on Friday, February 27th. Three research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $13.73.

Insider Activity

In related news, Director James D. Forbes acquired 5,000 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were purchased at an average price of $12.48 per share, with a total value of $62,400.00. Following the completion of the purchase, the director directly owned 10,000 shares of the company’s stock, valued at $124,800. This represents a 100.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gregory T. Lucier acquired 27,555 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was bought at an average cost of $14.24 per share, for a total transaction of $392,383.20. Following the purchase, the director directly owned 27,555 shares of the company’s stock, valued at approximately $392,383.20. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 70,000 shares of company stock worth $956,437 over the last three months. Insiders own 0.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Sivia Capital Partners LLC bought a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $389,000. Integrated Advisors Network LLC bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $205,000. Abel Hall LLC bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $148,000. BTG Pactual Asset Management US LLC bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $148,000. Finally, Wilmington Savings Fund Society FSB raised its stake in DENTSPLY SIRONA by 13.0% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 13,055 shares of the medical instruments supplier’s stock valued at $149,000 after purchasing an additional 1,500 shares during the period. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.